The goal for this meeting is to advance the exchange of information between leaders in aging research and biopharmaceutical companies looking to address the rapidly growing market for treatments of aging-associated diseases. In addition to covering such subjects as mitochondria, sirtuins, caloric restriction, and model organisms for aging, the conference will also deal with the business opportunity for pharmaceutical companies to develop drug pipelines based on research now being conducted in academia and smaller biotech companies.

Starting with our Chair Michael R. Rose and Keynote Speaker Leonard Guarente, the speaker line-up is filled with top-level scientists and business executives who are helping to identify opportunities for profitable aging research. The conference aims to provide maximum value to industry, academic and government decision makers, focusing on science and business applications

Attend this conference and you will:

1. Learn the latest cutting edge research

2. Set foundations for future partnerships

3. Source new drugs for licensing

4. Establish new relationships

5. Map future drug development strategies